Global Pharmaceutical Intermediates Market Insights And Forecast To 2028

1 Study Coverage
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market by Application
1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts 2017-2028
2.2 Global Pharmaceutical Intermediates Revenue Estimates and Forecasts 2017-2028
2.3 Global Pharmaceutical Intermediates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pharmaceutical Intermediates Sales by Region
2.4.1 Global Pharmaceutical Intermediates Sales by Region (2017-2022)
2.4.2 Global Sales Pharmaceutical Intermediates by Region (2023-2028)
2.5 Global Pharmaceutical Intermediates Revenue by Region
2.5.1 Global Pharmaceutical Intermediates Revenue by Region (2017-2022)
2.5.2 Global Pharmaceutical Intermediates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales (2017-2022)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharmaceutical Intermediates in 2021
3.2 Global Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturers (2017-2022)
3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2021
3.3 Global Pharmaceutical Intermediates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharmaceutical Intermediates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharmaceutical Intermediates Sales by Type
4.1.1 Global Pharmaceutical Intermediates Historical Sales by Type (2017-2022)
4.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Type (2023-2028)
4.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
4.2 Global Pharmaceutical Intermediates Revenue by Type
4.2.1 Global Pharmaceutical Intermediates Historical Revenue by Type (2017-2022)
4.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
4.3 Global Pharmaceutical Intermediates Price by Type
4.3.1 Global Pharmaceutical Intermediates Price by Type (2017-2022)
4.3.2 Global Pharmaceutical Intermediates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pharmaceutical Intermediates Sales by Application
5.1.1 Global Pharmaceutical Intermediates Historical Sales by Application (2017-2022)
5.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Application (2023-2028)
5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
5.2 Global Pharmaceutical Intermediates Revenue by Application
5.2.1 Global Pharmaceutical Intermediates Historical Revenue by Application (2017-2022)
5.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
5.3 Global Pharmaceutical Intermediates Price by Application
5.3.1 Global Pharmaceutical Intermediates Price by Application (2017-2022)
5.3.2 Global Pharmaceutical Intermediates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pharmaceutical Intermediates Market Size by Type
6.1.1 North America Pharmaceutical Intermediates Sales by Type (2017-2028)
6.1.2 North America Pharmaceutical Intermediates Revenue by Type (2017-2028)
6.2 North America Pharmaceutical Intermediates Market Size by Application
6.2.1 North America Pharmaceutical Intermediates Sales by Application (2017-2028)
6.2.2 North America Pharmaceutical Intermediates Revenue by Application (2017-2028)
6.3 North America Pharmaceutical Intermediates Market Size by Country
6.3.1 North America Pharmaceutical Intermediates Sales by Country (2017-2028)
6.3.2 North America Pharmaceutical Intermediates Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pharmaceutical Intermediates Market Size by Type
7.1.1 Europe Pharmaceutical Intermediates Sales by Type (2017-2028)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Type (2017-2028)
7.2 Europe Pharmaceutical Intermediates Market Size by Application
7.2.1 Europe Pharmaceutical Intermediates Sales by Application (2017-2028)
7.2.2 Europe Pharmaceutical Intermediates Revenue by Application (2017-2028)
7.3 Europe Pharmaceutical Intermediates Market Size by Country
7.3.1 Europe Pharmaceutical Intermediates Sales by Country (2017-2028)
7.3.2 Europe Pharmaceutical Intermediates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Intermediates Market Size by Type
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Type (2017-2028)
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Type (2017-2028)
8.2 Asia Pacific Pharmaceutical Intermediates Market Size by Application
8.2.1 Asia Pacific Pharmaceutical Intermediates Sales by Application (2017-2028)
8.2.2 Asia Pacific Pharmaceutical Intermediates Revenue by Application (2017-2028)
8.3 Asia Pacific Pharmaceutical Intermediates Market Size by Region
8.3.1 Asia Pacific Pharmaceutical Intermediates Sales by Region (2017-2028)
8.3.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pharmaceutical Intermediates Market Size by Type
9.1.1 Latin America Pharmaceutical Intermediates Sales by Type (2017-2028)
9.1.2 Latin America Pharmaceutical Intermediates Revenue by Type (2017-2028)
9.2 Latin America Pharmaceutical Intermediates Market Size by Application
9.2.1 Latin America Pharmaceutical Intermediates Sales by Application (2017-2028)
9.2.2 Latin America Pharmaceutical Intermediates Revenue by Application (2017-2028)
9.3 Latin America Pharmaceutical Intermediates Market Size by Country
9.3.1 Latin America Pharmaceutical Intermediates Sales by Country (2017-2028)
9.3.2 Latin America Pharmaceutical Intermediates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical Intermediates Market Size by Type
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2017-2028)
10.2 Middle East and Africa Pharmaceutical Intermediates Market Size by Application
10.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2017-2028)
10.3 Middle East and Africa Pharmaceutical Intermediates Market Size by Country
10.3.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Overview
11.1.3 Lonza Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lonza Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Overview
11.2.3 Catalent Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Catalent Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Catalent Recent Developments
11.3 Patheon
11.3.1 Patheon Corporation Information
11.3.2 Patheon Overview
11.3.3 Patheon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Patheon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Patheon Recent Developments
11.4 Jubilant
11.4.1 Jubilant Corporation Information
11.4.2 Jubilant Overview
11.4.3 Jubilant Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Jubilant Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jubilant Recent Developments
11.5 Granules
11.5.1 Granules Corporation Information
11.5.2 Granules Overview
11.5.3 Granules Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Granules Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Granules Recent Developments
11.6 Ganesh
11.6.1 Ganesh Corporation Information
11.6.2 Ganesh Overview
11.6.3 Ganesh Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ganesh Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ganesh Recent Developments
11.7 Chemcon
11.7.1 Chemcon Corporation Information
11.7.2 Chemcon Overview
11.7.3 Chemcon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Chemcon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Chemcon Recent Developments
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Overview
11.8.3 BASF Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BASF Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BASF Recent Developments
11.9 Porton
11.9.1 Porton Corporation Information
11.9.2 Porton Overview
11.9.3 Porton Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Porton Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Porton Recent Developments
11.10 Lianhetech
11.10.1 Lianhetech Corporation Information
11.10.2 Lianhetech Overview
11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lianhetech Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lianhetech Recent Developments
11.11 ABA Chem
11.11.1 ABA Chem Corporation Information
11.11.2 ABA Chem Overview
11.11.3 ABA Chem Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 ABA Chem Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ABA Chem Recent Developments
11.12 Tianma
11.12.1 Tianma Corporation Information
11.12.2 Tianma Overview
11.12.3 Tianma Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Tianma Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tianma Recent Developments
11.13 Jiujiujiu
11.13.1 Jiujiujiu Corporation Information
11.13.2 Jiujiujiu Overview
11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jiujiujiu Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiujiujiu Recent Developments
11.14 Alpha
11.14.1 Alpha Corporation Information
11.14.2 Alpha Overview
11.14.3 Alpha Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Alpha Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Alpha Recent Developments
11.15 Jiuzhou
11.15.1 Jiuzhou Corporation Information
11.15.2 Jiuzhou Overview
11.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Jiuzhou Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiuzhou Recent Developments
11.16 Yongtai
11.16.1 Yongtai Corporation Information
11.16.2 Yongtai Overview
11.16.3 Yongtai Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Yongtai Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Yongtai Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharmaceutical Intermediates Industry Chain Analysis
12.2 Pharmaceutical Intermediates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmaceutical Intermediates Production Mode & Process
12.4 Pharmaceutical Intermediates Sales and Marketing
12.4.1 Pharmaceutical Intermediates Sales Channels
12.4.2 Pharmaceutical Intermediates Distributors
12.5 Pharmaceutical Intermediates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharmaceutical Intermediates Industry Trends
13.2 Pharmaceutical Intermediates Market Drivers
13.3 Pharmaceutical Intermediates Market Challenges
13.4 Pharmaceutical Intermediates Market Restraints
14 Key Findings in The Global Pharmaceutical Intermediates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of GMP
Table 3. Major Manufacturers of Non-GMP
Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Pharmaceutical Intermediates Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pharmaceutical Intermediates Sales by Region (2017-2022) & (K MT)
Table 7. Global Pharmaceutical Intermediates Sales Market Share by Region (2017-2022)
Table 8. Global Pharmaceutical Intermediates Sales by Region (2023-2028) & (K MT)
Table 9. Global Pharmaceutical Intermediates Sales Market Share by Region (2023-2028)
Table 10. Global Pharmaceutical Intermediates Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Pharmaceutical Intermediates Revenue Market Share by Region (2017-2022)
Table 12. Global Pharmaceutical Intermediates Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Pharmaceutical Intermediates Revenue Market Share by Region (2023-2028)
Table 14. Global Pharmaceutical Intermediates Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2017-2022)
Table 16. Global Pharmaceutical Intermediates Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2017-2022)
Table 18. Pharmaceutical Intermediates Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2021)
Table 21. Pharmaceutical Intermediates Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pharmaceutical Intermediates Product Offered
Table 23. Date of Manufacturers Enter into Pharmaceutical Intermediates Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 26. Global Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 27. Global Pharmaceutical Intermediates Sales Share by Type (2017-2022)
Table 28. Global Pharmaceutical Intermediates Sales Share by Type (2023-2028)
Table 29. Global Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Pharmaceutical Intermediates Revenue Share by Type (2017-2022)
Table 32. Global Pharmaceutical Intermediates Revenue Share by Type (2023-2028)
Table 33. Pharmaceutical Intermediates Price by Type (2017-2022) & (USD/MT)
Table 34. Global Pharmaceutical Intermediates Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 36. Global Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 37. Global Pharmaceutical Intermediates Sales Share by Application (2017-2022)
Table 38. Global Pharmaceutical Intermediates Sales Share by Application (2023-2028)
Table 39. Global Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Pharmaceutical Intermediates Revenue Share by Application (2017-2022)
Table 42. Global Pharmaceutical Intermediates Revenue Share by Application (2023-2028)
Table 43. Pharmaceutical Intermediates Price by Application (2017-2022) & (USD/MT)
Table 44. Global Pharmaceutical Intermediates Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 46. North America Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 47. North America Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 50. North America Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 51. North America Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
Table 54. North America Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
Table 55. North America Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 58. Europe Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 59. Europe Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 62. Europe Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 63. Europe Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
Table 66. Europe Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
Table 67. Europe Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Pharmaceutical Intermediates Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Pharmaceutical Intermediates Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2023-2028) & (US$ Million)
Table 105. Lonza Corporation Information
Table 106. Lonza Description and Major Businesses
Table 107. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Lonza Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Lonza Recent Developments
Table 110. Catalent Corporation Information
Table 111. Catalent Description and Major Businesses
Table 112. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Catalent Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Catalent Recent Developments
Table 115. Patheon Corporation Information
Table 116. Patheon Description and Major Businesses
Table 117. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Patheon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Patheon Recent Developments
Table 120. Jubilant Corporation Information
Table 121. Jubilant Description and Major Businesses
Table 122. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Jubilant Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Jubilant Recent Developments
Table 125. Granules Corporation Information
Table 126. Granules Description and Major Businesses
Table 127. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Granules Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Granules Recent Developments
Table 130. Ganesh Corporation Information
Table 131. Ganesh Description and Major Businesses
Table 132. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Ganesh Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Ganesh Recent Developments
Table 135. Chemcon Corporation Information
Table 136. Chemcon Description and Major Businesses
Table 137. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Chemcon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Chemcon Recent Developments
Table 140. BASF Corporation Information
Table 141. BASF Description and Major Businesses
Table 142. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. BASF Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. BASF Recent Developments
Table 145. Porton Corporation Information
Table 146. Porton Description and Major Businesses
Table 147. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Porton Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Porton Recent Developments
Table 150. Lianhetech Corporation Information
Table 151. Lianhetech Description and Major Businesses
Table 152. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Lianhetech Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Lianhetech Recent Developments
Table 155. ABA Chem Corporation Information
Table 156. ABA Chem Description and Major Businesses
Table 157. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. ABA Chem Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. ABA Chem Recent Developments
Table 160. Tianma Corporation Information
Table 161. Tianma Description and Major Businesses
Table 162. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. Tianma Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Tianma Recent Developments
Table 165. Jiujiujiu Corporation Information
Table 166. Jiujiujiu Description and Major Businesses
Table 167. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 168. Jiujiujiu Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Jiujiujiu Recent Developments
Table 170. Alpha Corporation Information
Table 171. Alpha Description and Major Businesses
Table 172. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 173. Alpha Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Alpha Recent Developments
Table 175. Jiuzhou Corporation Information
Table 176. Jiuzhou Description and Major Businesses
Table 177. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 178. Jiuzhou Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Jiuzhou Recent Developments
Table 180. Yongtai Corporation Information
Table 181. Yongtai Description and Major Businesses
Table 182. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 183. Yongtai Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Yongtai Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Pharmaceutical Intermediates Distributors List
Table 188. Pharmaceutical Intermediates Customers List
Table 189. Pharmaceutical Intermediates Market Trends
Table 190. Pharmaceutical Intermediates Market Drivers
Table 191. Pharmaceutical Intermediates Market Challenges
Table 192. Pharmaceutical Intermediates Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 3. Global Pharmaceutical Intermediates Market Share by Type in 2021 & 2028
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Market Share by Application in 2021 & 2028
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Sales 2017-2028 (K MT)
Figure 12. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pharmaceutical Intermediates Revenue 2017-2028 (US$ Million)
Figure 14. Global Pharmaceutical Intermediates Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region (2017-2022)
Figure 16. Global Pharmaceutical Intermediates Sales Market Share by Region (2023-2028)
Figure 17. North America Pharmaceutical Intermediates Sales YoY (2017-2028) & (K MT)
Figure 18. North America Pharmaceutical Intermediates Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pharmaceutical Intermediates Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Pharmaceutical Intermediates Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pharmaceutical Intermediates Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Pharmaceutical Intermediates Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pharmaceutical Intermediates Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Pharmaceutical Intermediates Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pharmaceutical Intermediates Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Pharmaceutical Intermediates Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pharmaceutical Intermediates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pharmaceutical Intermediates in the World: Market Share by Pharmaceutical Intermediates Revenue in 2021
Figure 29. Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 31. Global Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 32. Global Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 33. Global Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 34. North America Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 35. North America Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 36. North America Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 37. North America Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 38. North America Pharmaceutical Intermediates Sales Share by Country (2017-2028)
Figure 39. North America Pharmaceutical Intermediates Revenue Share by Country (2017-2028)
Figure 40. U.S. Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 43. Europe Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 45. Europe Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pharmaceutical Intermediates Sales Share by Country (2017-2028)
Figure 47. Europe Pharmaceutical Intermediates Revenue Share by Country (2017-2028)
Figure 48. Germany Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 49. France Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pharmaceutical Intermediates Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pharmaceutical Intermediates Revenue Share by Region (2017-2028)
Figure 59. China Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 62. India Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 69. Latin America Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 71. Latin America Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Pharmaceutical Intermediates Sales Share by Country (2017-2028)
Figure 73. Latin America Pharmaceutical Intermediates Revenue Share by Country (2017-2028)
Figure 74. Mexico Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pharmaceutical Intermediates Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Pharmaceutical Intermediates Revenue Share by Country (2017-2028)
Figure 83. Turkey Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Pharmaceutical Intermediates Revenue (2017-2028) & (US$ Million)
Figure 86. Pharmaceutical Intermediates Value Chain
Figure 87. Pharmaceutical Intermediates Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.